ERBB2 and breast cancer: There was no observational study discussed solely for LM of HER2-positive BC (Table 2), indicating that there is still a dearth of attention on LM of HER2-positive BC, which necessitates further efforts and exploration, also may be due to premature cases inclusion (during a time when the idea of HER2 was unknown) and the difficulty in case collection.